Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycloome (0.05% cyclosporine) after cataract surgery in patients with dry eye
ChiCTR2200063490Phase 4Not yet recruiting
- Sponsor
- Shenyang Aier Excellence Eye Hospital
- Start
- Aug 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of cyclosporine in dry eye syndrome (DED) and senile cataract (ARC) (2 arms), sponsored by Shenyang Aier Excellence Eye Hospital. Primary endpoints: Keratograph ocular surface comprehensive analysis, Ocular Surface Disease Index (OSDI) and 1 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)senile cataract (ARC)
Beyond the preview
Go deeper on ChiCTR2200063490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063490.